A simple two-step approach for introducing a protected diaminedithiol chelator during solid-phase assembly of peptides

被引:19
作者
Gariépy, J
Rémy, S
Zhang, XG
Ballinger, JR
Bolewska-Pedyczak, E
Rauth, M
Bisland, SK
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Div Mol & Struct Biol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
关键词
D O I
10.1021/bc0100814
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple synthetic strategy is described to incorporate a protected diaminedithiol (N2S2) chelator during Fmoc solid-phase synthesis of short peptides. The resulting constructs could be efficiently labeled with technetium-99m (Tc-99m). The chelator was assembled at the N-terminus of peptides in a two-step procedure where the deprotected terminal amino group was first reacted with di-Fmoc-diaminopropionic acid (Fmoc-DAP-[Fmoc]-OH). The two protected amino groups were then simultaneously deprotected and subsequently reacted with S-benzoylthiolglycolic acid (TGA) to generate a protected N2S2 chelator. This metal binding site was introduced into di- and tripeptides. Each peptide construct was composed of a C-terminal lysine residue and an N-terminal diaminopropionic moiety modified to create the chelator site. The c-amino group at the C-terminal lysine was further derivatized with a nitroimidazole group to facilitate cellular retention. The resulting constructs were then cleaved from the resin support, purified, and labeled with [Tc-99m]pertechnetate. Six constructs were prepared differing by a single amino acid inserted between the diaminopropionic acid and lysine residues. Optimal labeling yields of >70% were achieved around neutral pH and heating at 75 degreesC for 10 min. Purified Tc-99m-labeled constructs were found to accumulate in Chinese hamster ovary (CHO) cells in vitro as a function of charge and hydrophobicity.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 24 条
[1]   SYNTHESIS OF A DIEPITOPE MULTIPLE ANTIGEN PEPTIDE-CONTAINING SEQUENCES FROM 2 MALARIA ANTIGENS USING FMOC CHEMISTRY [J].
AHLBORG, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 179 (02) :269-275
[2]  
BODANSKY M, 1984, PRACTISE PEPTIDE SYN, V21, P24
[3]   NHS-MAS3:: a bifunctional chelator alternative to NHS-MAG3 [J].
Chang, F ;
Qu, T ;
Rusckowski, M ;
Hnatowich, DJ .
APPLIED RADIATION AND ISOTOPES, 1999, 50 (04) :723-732
[4]   An appraisal of new variants of Dde amine protecting group for solid phase peptide synthesis [J].
Chhabra, SR ;
Hothi, B ;
Evans, DJ ;
White, PD ;
Bycroft, BW ;
Chan, WC .
TETRAHEDRON LETTERS, 1998, 39 (12) :1603-1606
[5]  
FRITZBERG AR, 1982, J NUCL MED, V23, P592
[6]  
Hnatowich DJ, 1998, J NUCL MED, V39, P56
[7]   Solid-phase synthesis and application of double-fluorescent-labeled lipopeptides, containing a CTL-epitope from the measles fusion protein [J].
Hoogerhout, P ;
Stittelaar, KJ ;
Brugghe, HF ;
Timmermans, JAM ;
ten Hove, GJ ;
Jiskoot, W ;
Hoekman, JHG ;
Roholl, PJM .
JOURNAL OF PEPTIDE RESEARCH, 1999, 54 (05) :436-443
[8]   COLOR TEST FOR DETECTION OF FREE TERMINAL AMINO GROUPS IN SOLID-PHASE SYNTHESIS OF PEPTIDES [J].
KAISER, E ;
COLESCOT.RL ;
BOSSINGE.CD ;
COOK, PI .
ANALYTICAL BIOCHEMISTRY, 1970, 34 (02) :595-&
[9]  
Lister-James J, 1996, Q J Nucl Med, V40, P221
[10]  
ListerJames J, 1996, J NUCL MED, V37, P775